Shilei Liu

机构：XinHua Hospital · ORCID：0000-0003-1700-4385

发表论文 66 篇 · 总被引 938 次 · h-index 18

代表论文

• Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial (2024 · 癌症：英文版 · 被引 45)
• LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer (2022 · Cancer Letters · 被引 45)
• Identification of a lncRNA/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis (2024 · Journal of Cancer · 被引 31)
• Inhibition of XPO1 with KPT-330 induces autophagy-dependent apoptosis in gallbladder cancer by activating the p53/mTOR pathway (2022 · Journal of Translational Medicine · 被引 28)
• DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis (2023 · Cellular Signalling · 被引 25)
• UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway (2022 · Cell Death Discovery · 被引 25)